Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,784 total articles

Himax to Showcase Industry-Leading High-Contrast Dual-Edge Front-lit LCoS Microdisplay at SID Display Week 2026

Himax to Showcase Industry-Leading High-Contrast Dual-Edge Front-lit LCoS Microdisplay at SID Display Week 2026

Himax Technologies announced new advancements in its high-contrast dual-edge front-lit LCoS microdisplay at SID Display Week 2026, featuring enhanced contrast, improved optical efficiency, and miniaturized integration for augmented reality glasses. The technology delivers significantly sharper image clarity and dynamic range improvements suitable f…

Woodward Partners with Lufthansa Technik as an Elite-Level Licensed Repair Service Facility for CFM LEAP Engine Controls

Woodward Partners with Lufthansa Technik as an Elite-Level Licensed Repair Service Facility for CFM LEAP Engine Controls

Woodward, Inc. has partnered with Lufthansa Technik to designate Lufthansa as an Elite Licensed Repair Service Facility for Woodward components on CFM International LEAP-1A and LEAP-1B engines. This agreement expands repair and overhaul capabilities at Lufthansa Technik, enhancing service for operators of Airbus A320neo and Boeing 737 MAX aircraft.…

Maze Therapeutics Announces $150 Million Registered Offering

Maze Therapeutics Announces $150 Million Registered Offering

Maze Therapeutics, a clinical-stage biopharmaceutical company focused on kidney and metabolic diseases, announced an underwritten registered offering of 5.54 million common shares and pre-funded warrants totaling $150 million. The proceeds will primarily advance their drug candidates MZE829 for APOL1-mediated kidney disease and MZE782 for phenylket…

At Sea-Air-Space 2026, HII’s Newport News Shipbuilding President Reinforces Support for Expanding U.S. Shipbuilding Capacity

At Sea-Air-Space 2026, HII’s Newport News Shipbuilding President Reinforces Support for Expanding U.S. Shipbuilding Capacity

At Sea-Air-Space Expo 2026, Kari Wilkinson, President of Newport News Shipbuilding and HII EVP, highlighted HII's initiatives to expand U.S. shipbuilding capacity by growing its workforce, adopting advanced technologies, and promoting distributed shipbuilding across the country. HII reaffirms its role as America's largest military shipbuilder and a…

Home BancShares, Inc. Announces Second Quarter Dividend

Home BancShares, Inc. Announces Second Quarter Dividend

Home BancShares, Inc., parent company of Centennial Bank, announced a quarterly cash dividend of $0.21 per share for the second quarter, payable on June 3, 2026, consistent with the first quarter payout. The dividend reflects the company's stable financial position and ongoing commitment to returning value to shareholders.

Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026

Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026

Ascentage Pharma announced that six abstracts from clinical studies of its key drug candidates will be presented at the 2026 ASCO Annual Meeting, highlighting clinical progress in oncology drug development. Presentations include rapid oral presentations on Olverembatinib, Lisaftoclax, and Alrizomadlin, underlining the company's ongoing global clini…

Netskope Announces AI Guardrails Solution Powered by Google Cloud TPUs to Help Secure High-Performance AI Workflows at Scale

Netskope Announces AI Guardrails Solution Powered by Google Cloud TPUs to Help Secure High-Performance AI Workflows at Scale

Netskope announced an expanded partnership with Google Cloud to launch Netskope One AI Guardrails, a new solution integrating Google Cloud TPUs and Vertex AI to secure high-performance generative AI and autonomous agent workflows. This offering provides real-time safety checks, behavioral protections against AI-specific threats, and compliance supp…

Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting

Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting

Kyverna Therapeutics reported positive primary analysis results from its registrational Phase 2 KYSA-8 trial of miv-cel, an autologous CD19-targeting CAR T-cell therapy, in patients with Stiff Person Syndrome (SPS). Miv-cel demonstrated statistically significant improvements in mobility and disability scores, eliminated the need for chronic immunot…

Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting

Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting

Revolution Medicines presented updated Phase 1/2 clinical trial data for daraxonrasib, an oral RAS(ON) multi-selective inhibitor, in previously untreated metastatic pancreatic ductal adenocarcinoma (PDAC). The findings demonstrate manageable safety profiles and encouraging antitumor activity in both monotherapy and combination with chemotherapy, su…

Equus Announces Fourth Quarter Net Asset Value

Equus Announces Fourth Quarter Net Asset Value

Equus Total Return, Inc. reported a significant decrease in net asset value (NAV) per share to $1.19 at the end of Q4 2025 from $1.90 at the end of Q3 2025. This decline was primarily driven by a $12.35 million decrease in the fair value of its investment in Morgan E&P, Inc., linked to lower oil forward prices and elimination of some reserves. Conv…

Liberty Defense Announces Pricing of its U.S. Initial Public Offering

Liberty Defense Announces Pricing of its U.S. Initial Public Offering

Liberty Defense Holdings Ltd. has priced its initial public offering (IPO) in the United States, offering 3.67 million common shares at $4.50 per share and pre-funded warrants to raise about $20 million gross proceeds. The company's common shares will begin trading on the Nasdaq Capital Market on April 22, 2026 under ticker DETX, while delisting fr…

Greenlane Holdings Announces Upcoming Pre-Funded Warrant Conversion and Lock-Up of Strategic Advisor Warrants

Greenlane Holdings Announces Upcoming Pre-Funded Warrant Conversion and Lock-Up of Strategic Advisor Warrants

Greenlane Holdings, Inc., a Nasdaq-listed digital asset treasury company focused on the Berachain blockchain, announced that Berachain Investment Corporation will convert a portion of its pre-funded warrants into common stock while adhering to beneficial ownership limits. Additionally, strategic advisor warrant holders from the company's recent PIP…

Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Aktis Oncology announced the presentation of initial clinical imaging and dosimetry data for their radioconjugate AKY-2519 targeting B7-H3 expressing solid tumors at the 2026 ASCO Annual Meeting. The company received FDA clearance to initiate a Phase 1b clinical trial of AKY-2519 mid-2026. AKY-2519 is Aktis's second clinical-stage radioconjugate de…

Toll Brothers to Acquire Private Home Builder in Northwest Arkansas

Toll Brothers to Acquire Private Home Builder in Northwest Arkansas

Toll Brothers, the US luxury homebuilder, announced a definitive agreement to acquire Buffington Homes of Arkansas, gaining a strong presence in the Fayetteville/Bentonville housing market. Buffington Homes is the largest luxury home builder in northwest Arkansas with over 1,500 lots. This acquisition supports Toll Brothers’ growth strategy, levera…